← All news
Markets

Capricor (CAPR) Closed 58% Higher on an FDA Lifeline. Is Approval Really Back on Track?

1 source ·1 article ·Aug 20, 00:31 UTC Capricor Therapeutics

Covered by 1 outlet

All coverage · 1 article